Bloomage Biotechnology Corp Ltd (688363) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bloomage Biotechnology Corp Ltd (688363) has a cash flow conversion efficiency ratio of 0.013x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥93.75 Million ≈ $13.72 Million USD) by net assets (CN¥7.09 Billion ≈ $1.04 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 688363 market cap overview for the company's overall valuation and market capitalisation.
Bloomage Biotechnology Corp Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how Bloomage Biotechnology Corp Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Bloomage Biotechnology Corp Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bloomage Biotechnology Corp Ltd ranked by their cash flow conversion efficiency. Explore Bloomage Biotechnology Corp Ltd cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
KCE Electronics Public Company Limited
BK:KCE
|
0.048x |
|
Sumitomo Chemical India Limited
NSE:SUMICHEM
|
0.136x |
|
Pharvaris BV
NASDAQ:PHVS
|
-0.126x |
|
Warby Parker Inc
NYSE:WRBY
|
0.076x |
|
Visteon Corp
NASDAQ:VC
|
0.071x |
|
Four Corners Property Trust Inc
NYSE:FCPT
|
0.031x |
|
Mivne Real Estate KD Ltd
TA:MVNE
|
0.038x |
|
Rogers Corporation
NYSE:ROG
|
0.005x |
Annual Cash Flow Conversion Efficiency for Bloomage Biotechnology Corp Ltd (2012–2025)
The table below shows the annual cash flow conversion efficiency of Bloomage Biotechnology Corp Ltd from 2012 to 2025. View 688363 live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥7.12 Billion ≈ $1.04 Billion |
CN¥627.45 Million ≈ $91.82 Million |
0.088x | +6.85% |
| 2024-12-31 | CN¥6.84 Billion ≈ $1.00 Billion |
CN¥564.51 Million ≈ $82.60 Million |
0.083x | -17.62% |
| 2023-12-31 | CN¥6.98 Billion ≈ $1.02 Billion |
CN¥699.65 Million ≈ $102.38 Million |
0.100x | +5.41% |
| 2022-12-31 | CN¥6.68 Billion ≈ $977.93 Million |
CN¥635.19 Million ≈ $92.95 Million |
0.095x | -57.53% |
| 2021-12-31 | CN¥5.70 Billion ≈ $834.45 Million |
CN¥1.28 Billion ≈ $186.73 Million |
0.224x | +61.67% |
| 2020-12-31 | CN¥5.09 Billion ≈ $745.44 Million |
CN¥705.12 Million ≈ $103.18 Million |
0.138x | +72.58% |
| 2019-12-31 | CN¥4.55 Billion ≈ $665.74 Million |
CN¥364.89 Million ≈ $53.40 Million |
0.080x | -68.86% |
| 2018-12-31 | CN¥1.72 Billion ≈ $251.32 Million |
CN¥442.30 Million ≈ $64.72 Million |
0.258x | +22.81% |
| 2017-12-31 | CN¥1.64 Billion ≈ $239.65 Million |
CN¥343.42 Million ≈ $50.25 Million |
0.210x | +9.39% |
| 2016-12-31 | CN¥1.26 Billion ≈ $184.47 Million |
CN¥241.68 Million ≈ $35.36 Million |
0.192x | +56.87% |
| 2015-12-31 | CN¥1.19 Billion ≈ $174.42 Million |
CN¥145.67 Million ≈ $21.32 Million |
0.122x | -33.10% |
| 2014-12-31 | CN¥752.51 Million ≈ $110.12 Million |
CN¥137.47 Million ≈ $20.12 Million |
0.183x | -33.62% |
| 2013-12-31 | CN¥564.35 Million ≈ $82.58 Million |
CN¥155.33 Million ≈ $22.73 Million |
0.275x | +24.08% |
| 2012-12-31 | CN¥376.97 Million ≈ $55.16 Million |
CN¥83.62 Million ≈ $12.24 Million |
0.222x | -- |
About Bloomage Biotechnology Corp Ltd
Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers beauty and care products under brand Hymagic-VCHA VC Hylauronic Acid; Biomeet-MarineDNA; Bioyouth-SPG Schizophyllan Gel; Hymagic-GluHA; Bloomsurfact EncapCare RP; Bloomsurfact Sodium Surfactin; Hybloom Minitrue; Bioyouth-EGT Pure Ultrapure Ergothioneine; miniHA HA-Oligo degraded by… Read more